Children and adolescents
Pramipexol Sandoz Farmacéutica is not recommended for use in children or adolescents under 18 years old.
Other medications and Pramipexol Sandoz
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.This includes medications, herbal remedies, natural foods or nutritional supplements that you have obtained without a prescription.
Avoid using pramipexol with antipsychotic medications.
Be cautious if you are using the following medications:
If you are using levodopa, it is recommended to reduce the dose of levodopa when starting treatment with Pramipexol Sandoz Farmacéutica.
Be cautious if you are using tranquilizers (sedative effect) or if you drink alcohol. In these cases, pramipexol may affect your ability to drive and operate machinery.
Taking Pramipexol Sandoz Farmacéutica with food, drinks, and alcohol
You should be cautious if you drink alcohol during treatment with pramipexol.
You can take pramipexol with or without food.
Pregnancy, lactation, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.Your doctor will tell you if you should continue treatment with pramipexol.
The effect of pramipexol on the fetus is unknown. Therefore, do not take pramipexol if you are pregnant unless your doctor tells you to.
Pramipexol should not be used during breastfeeding. Pramipexol may decrease milk production. Additionally, pramipexol may pass into breast milk and reach your baby. If the use of pramipexol is necessary, breastfeeding should be discontinued.
Consult your doctor or pharmacist before using any medication.
Driving and operating machinery
Pramipexol may cause hallucinations (seeing, hearing, or feeling things that are not present). If this happens, do not drive or operate machinery.
Pramipexol has been associated with drowsiness and sudden episodes of sleep, especially in patients with Parkinson's disease. If you experience these adverse effects, do not drive or operate machinery. Inform your doctor if this happens.
Take Pramipexol Sandoz Farmacéutica prolonged-release tablets once a day and at the same hour every day.
You can take pramipexol with or without food. The tablets should be swallowed whole with water.
Do not chew, break, or crush the prolonged-release tablets. If you do, there is a risk of overdose, as the medication may be released in your body too quickly.
During the first week, the usual daily dose is 0.26 mg of pramipexol.
This dose will be increased every 5-7 days according to your doctor's instructions, until your symptoms are controlled (maintenance dose).
Dosage escalation schedule for Pramipexol Sandoz Farmacéutica prolonged-release tablets | ||
Week | Daily dose (mg) | Number of tablets |
1 | 0.26 | 1 prolonged-release tablet of Pramipexol Sandoz Farmacéutica 0.26 mg |
2 | 0.52 | 1 prolonged-release tablet of Pramipexol Sandoz Farmacéutica 0.56 mg 2 prolonged-release tablets of Pramipexol Sandoz Farmacéutica 0.26 mg |
3 | 1.05 | 1 prolonged-release tablet of Pramipexol Sandoz Farmacéutica 1.05 mg 2 prolonged-release tablets of Pramipexol Sandoz Farmacéutica 0.52 mg 4 prolonged-release tablets of Pramipexol Sandoz Farmacéutica 0.26 mg |
The usual maintenance dose is 1.05 mg per day. However, it may be necessary to increase your dose. If necessary, your doctor may increase your dose of tablets up to a maximum of 3.15 mg of pramipexol per day. It is also possible to reduce the maintenance dose to 1 prolonged-release tablet of Pramipexol Sandoz Farmacéutica 0.26 mg per day.
Patients with kidney disease
If you have kidney disease, your doctor may advise you to take the usual starting dose of 0.26 mg prolonged-release tablets every other day during the first week.
After that, your doctor may increase the frequency of doses to 1 prolonged-release tablet of 0.26 mg per day. If necessary, your doctor may adjust your dose in increments of 0.26 mg of pramipexol.
If you have severe kidney disease, your doctor may consider it necessary to switch you to a different pramipexol medication. If your kidney problems worsen during treatment, contact your doctor as soon as possible.
If you are changing from Pramipexol immediate-release tablets
Your doctor will base your dose of pramipexol prolonged-release tablets on the dose of Pramipexol immediate-release tablets you were taking.
The day before the change, take your Pramipexol immediate-release tablets as you normally would. The next morning, take your pramipexol prolonged-release tablet and do not take any more Pramipexol immediate-release tablets.
If you take more Pramipexol Sandoz Farmacéutica than you should
If you accidentally take too many tablets, consult your doctor or the nearest hospital emergency service immediately.
If you have taken more Pramipexol Sandoz Farmacéutica than you should, consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount used.
If you forget to take Pramipexol Sandoz Farmacéutica
If you forget to take your Pramipexol Sandoz Farmacéutica dose, but remember to take it within 12 hours of your usual time, take your tablet and continue with the next tablet at your usual time.
If you forget to take your dose more than 12 hours after your usual time, simply take the next dose at your usual time. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Pramipexol Sandoz Farmacéutica
Do not stop your treatment with Pramipexol Sandoz Farmacéutica without consulting your doctor first. If you need to stop your treatment with this medication, your doctor will gradually reduce your dose. This reduces the risk of worsening your symptoms.
If you have Parkinson's disease, do not stop your treatment with pramipexol abruptly. Sudden discontinuation may cause the appearance of a condition called neuroleptic malignant syndrome, which can pose a significant risk to your health. These symptoms include:
If you stop treatment or reduce the dose of Pramipexol Sandoz Farmacéutica, you may also experience a medical condition called dopamine agonist withdrawal syndrome.
The symptoms include depression, apathy, anxiety, fatigue, sweating, or pain. If you experience these symptoms, you should contact your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may cause side effects, although not everyone will experience them. The classification of side effects is based on the following frequencies:
Very common | may affect more than 1 in 10 people |
Common | may affect up to 1 in 10 people |
Uncommon | may affect up to 1 in 100 people |
Rare | may affect up to 1 in 1,000 people |
Very rare | may affect up to 1 in 10,000 people |
Frequency not known | cannot be estimated from available data |
You may experience the following side effects:
Very common:
Common:
Uncommon:
Rare:
Frequency not known:
Inform your doctor if you experience any of these behaviors; he will explain how to manage or reduce the symptoms.
The side effects marked with * cannot be precisely estimated in frequency, as these side effects were not observed in clinical trials involving 2,762 patients treated with pramipexol. The frequency category is likely not higher than "uncommon".
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after “CAD/EXP”. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Dispose of unused medications through the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Pramipexol Sandoz Pharmaceutical 0.26 mg Composition
Pramipexol Sandoz Pharmaceutical 1.05 mg Composition
Pramipexol Sandoz Pharmaceutical 2.1 mg Composition
Product Appearance and Packaging Contents
Pramipexol Sandoz Pharmaceutical 0.26 mg are prolonged-release tablets, white or almost white, cylindrical, flat, and beveled, marked with 026 on one face. Each package contains 30 tablets.
Pramipexol Sandoz Pharmaceutical 1.05 mg are prolonged-release tablets, white or almost white, cylindrical, and biconvex, marked with 105 on one face. Each package contains 30 tablets.
Pramipexol Sandoz Pharmaceutical 2.1 mg are prolonged-release tablets, white or almost white, cylindrical, and biconvex, marked with 210 on one face. Each package contains 30 tablets.
Marketing Authorization Holder and Responsible Manufacturer
Marketing Authorization Holder
Sandoz Pharmaceutical, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Responsible Manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos
Madrid (SPAIN)
or
Ferrer Internacional, S.A.
Joan Buscallà, 1-9, 08173 Sant Cugat del Vallés
Barcelona (SPAIN)
Last review date of this leaflet: January 2025
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.